Predicting the impact of treatments over time with uncertainty aware neural differential equations
Edward De Brouwer, Javier Gonz\'alez Hern\'andez, Stephanie Hyland

TL;DR
This paper introduces CF-ODE, a neural differential equation model that predicts treatment effects over time with uncertainty quantification, improving accuracy and reliability in observational data scenarios.
Contribution
The paper presents a novel Neural ODE-based method, CF-ODE, that models treatment impacts continuously over time with uncertainty estimates, addressing confounding issues.
Findings
CF-ODE outperforms existing methods in prediction accuracy.
CF-ODE provides reliable uncertainty estimates.
The method is effective across multiple longitudinal datasets.
Abstract
Predicting the impact of treatments from observational data only still represents a majorchallenge despite recent significant advances in time series modeling. Treatment assignments are usually correlated with the predictors of the response, resulting in a lack of data support for counterfactual predictions and therefore in poor quality estimates. Developments in causal inference have lead to methods addressing this confounding by requiring a minimum level of overlap. However,overlap is difficult to assess and usually notsatisfied in practice. In this work, we propose Counterfactual ODE (CF-ODE), a novel method to predict the impact of treatments continuously over time using Neural Ordinary Differential Equations equipped with uncertainty estimates. This allows to specifically assess which treatment outcomes can be reliably predicted. We demonstrate over several longitudinal data sets…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Causal Inference Techniques · Statistical Methods in Clinical Trials · Health Systems, Economic Evaluations, Quality of Life
